256 related articles for article (PubMed ID: 18386139)
21. Prostate cancer in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Gordon C; Clarke AE
Int J Cancer; 2011 Dec; 129(12):2966-9. PubMed ID: 21448902
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of malignancy in patients with systemic lupus erythematosus.
Ramsey-Goldman R; Mattai SA; Schilling E; Chiu YL; Alo CJ; Howe HL; Manzi S
J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
[TBL] [Abstract][Full Text] [Related]
23. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
[TBL] [Abstract][Full Text] [Related]
24. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.
Mok CC; Ho LY; To CH
Scand J Rheumatol; 2009; 38(5):362-8. PubMed ID: 19296403
[TBL] [Abstract][Full Text] [Related]
25. Risk of malignancy in women with systemic lupus erythematosus.
Sweeney DM; Manzi S; Janosky J; Selvaggi KJ; Ferri W; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
[TBL] [Abstract][Full Text] [Related]
26. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
27. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.
Tse SM; Mok CC
Lupus; 2017 Jun; 26(7):715-722. PubMed ID: 27831540
[TBL] [Abstract][Full Text] [Related]
28. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
29. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
Wang LH; Wang WM; Lin SH; Shieh CC
Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
[TBL] [Abstract][Full Text] [Related]
30. Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.
Dey D; Kenu E; Isenberg DA
Lupus; 2013 Aug; 22(9):919-27. PubMed ID: 23857987
[TBL] [Abstract][Full Text] [Related]
31. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.
Bernatsky S; Ramsey-Goldman R; Foulkes WD; Gordon C; Clarke AE
Br J Cancer; 2011 Apr; 104(9):1478-81. PubMed ID: 21487409
[TBL] [Abstract][Full Text] [Related]
32. Cancer risk in childhood-onset systemic lupus.
Bernatsky S; Clarke AE; Labrecque J; von Scheven E; Schanberg LE; Silverman ED; Brunner HI; Haines KA; Cron RQ; O'Neil KM; Oen K; Rosenberg AM; Duffy CM; Joseph L; Lee JL; Kale M; Turnbull EM; Ramsey-Goldman R
Arthritis Res Ther; 2013; 15(6):R198. PubMed ID: 24267155
[TBL] [Abstract][Full Text] [Related]
33. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden.
Nived O; Bengtsson A; Jönsen A; Sturfelt G; Olsson H
Lupus; 2001; 10(7):500-4. PubMed ID: 11480849
[TBL] [Abstract][Full Text] [Related]
34. Systemic lupus erythematosus and malignancies risk.
Mao S; Shen H; Zhang J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):253-62. PubMed ID: 26319223
[TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Ho LY; Yu KL; To CH
Clin Rheumatol; 2010 Jun; 29(6):599-604. PubMed ID: 20101427
[TBL] [Abstract][Full Text] [Related]
36. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus and thyroid disease: A 10-year study.
Lin WY; Chang CL; Fu LS; Lin CH; Lin HK
J Microbiol Immunol Infect; 2015 Dec; 48(6):676-83. PubMed ID: 24874431
[TBL] [Abstract][Full Text] [Related]
38. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study.
Chang SH; Park JK; Lee YJ; Yang JA; Lee EY; Song YW; Lee EB
Arthritis Res Ther; 2014 Aug; 16(4):428. PubMed ID: 25163486
[TBL] [Abstract][Full Text] [Related]
40. Comparative Fracture Risks Among United States Medicaid Enrollees With and Those Without Systemic Lupus Erythematosus.
Tedeschi SK; Kim SC; Guan H; Grossman JM; Costenbader KH
Arthritis Rheumatol; 2019 Jul; 71(7):1141-1146. PubMed ID: 30714690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
